Hypertrophic Cardiomyopathy Podcast Series

In this On Demand video, Dr. Steve Ommen and Dr. Carolyn Ho discuss recent updates to the 2024 Guideline for the Management of Hypertrophic Cardiomyopathy (HCM). Watch now to enhance your knowledge on the importance of shared decision-making, the use of cardiac myosin inhibitors to treat symptomatic obstructive HCM, and risk stratification for atrial fibrillation to improve patient outcomes.

It is estimated that 1 in every 500 adults living in the U.S. have HCM, but a large percentage of patients are undiagnosed.  Listen to this podcast to gain insight into hypertrophic cardiomyopathy (HCM) screening and what it means to your patients.

Making the correct of hypertrophic cardiomyopathy (HCM) is critical in being able to initiate early surveillance and therapy to improve patient outcomes.  In this podcast focusing on pharmacologic treatment options, learn more about completed and ongoing myosin inhibitor clinical trials.

Accurate diagnosis of Hypertrophic Cardiomyopathy (HCM) is critical. HCM is a chronic and progressive disease putting patients at risk of serious complications and co-morbidities.  Early and correct detection may help reduce some of the consequences of HCM and improve outcomes. In this podcast, learn more about how to distinguish phenocopies from HCM.

Diagnosis of hypertrophic cardiomyopathy is typically done by echocardiogram to assess the thickness of the heart muscle and observe blood flow in and out of the heart. In this podcast, learn more about how echocardiography is used in the diagnosis, screening, and management of HCM.

Hypertrophic cardiomyopathy (HCM) is the most common form of inherited heart disease and can affect people of any age. In this episode, learn what causes hypertrophic cardiomyopathy in children and the clinical and genetic screening needed to diagnosis HCM.

Although the cardiovascular and overall health benefits of regular activity are well-established, recommendations for recreational exercise and competitive sports participation for patients with HCM have been challenging. Listen to this podcast as Drs. Abraham, Day, and Martinez along with Brian Metz discuss exercising with HCM and the importance of shared decision making with the healthcare team.

Hypertrophic cardiomyopathy (HCM) is the most common form of genetic heart disease and can affect people of any age, yet it often goes undiagnosed. Genetic testing and counseling plays an important role in the diagnosis and management of HCM in patients in families. Learn more about genetic testing and counseling, and its impact on the patient's family.

People with HCM are at increased risk for developing arrythmias such as atrial fibrillation, suffering from stroke and even sudden cardiac arrest. People with HCM face a risk of death more than 3 times greater than the average person of the same age without HCM. Learn more about the complex relation between atrial fibrillation and hypertrophic cardiomyopathy.

Surgical and interventional options such as surgical myectomy or alcohol septal ablation may help those with obstructive Hypertrophic Cardiomyopathy (HCM) to reduce or remove the obstruction. A similar option is unavailable to those with non-obstructive HCM.  Heart transplants are considered as a last resort for HCM patients who progress to end stages of the disease.  Learn more about advanced surgical approaches and emerging medical therapies for HCM.

The American Heart Association is committed to being your resource for diagnosing and treating patients with hypertrophic cardiomyopathy (HCM).  Listen today to Hypertrophic Cardiomyopathy: Diagnosis and Clinical Implications of Structural Phenotypes.

Invasive Strategies: Percutaneous and Surgical is a discussion on hypertrophic cardiomyopathy exploring invasive strategies for patients with HCM, including both percutaneous and surgical approaches.

Some people with HCM experience symptoms such as fatigue, fainting, shortness of breath, chest pain or palpitations. Learn more on symptoms of Hypertrophic Cardiomyopathy. Get the resources you need to help more patients with HCM. Listen now! 

Differential diagnosis of HCM compared to other diseases, patient cases

Focus on appropriate selection of patients for ICD therapy, including assessment of risk factors and a comprehensive discussion of risks and benefits of ICD therapy in this specific patient population.

This podcast on hypertrophic cardiomyopathy, covers the natural history of the disease with a focus on the patient's perspective, tracking patient's symptoms and function, as far as disease progression is concerned, exploring the nuances of obstructive and non-obstructive forms of this disease, how it's managed depending on its form, and what is the burden that this disease brings to both patients and clinicians worldwide.

Hypertrophic Cardiomyopathy  is a disease condition that has over seven decades of knowledge. HCM manifests as 3 clinical pathways and may be synonymous with a normal lifespan with currently available therapies. Listen to Dr. Robert Fraser, Dr. Miguel Leal, and Dr. Ferhaan Ahmad provide an introduction of Hypertrophic Cardiomyopathy  and help improve the care of affected patients through early symptom recognition, diagnosis, and treatment.

Learn how to distinguish hypertrophic cardiomyopathy (HCM) from other disorders that can look like HCM. Listen as Dr. Vlad Zaha and Dr. Ferhaan Ahmad discuss how healthcare professional make a diagnosis of HCM and how they distinguish it from other disorders and the complex nature of diagnosing hypertrophic cardiomyopathy.